News

DataM Intelligence | competitive Intelligence Hunter Syndrome treatment is evolving with gene therapies and CNS-targeted ERTs challenging E ...
How can we properly prepare for reshoring while ensuring we're building tomorrow's manufacturing infrastructure today?
Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...
Venezuela Investigation Unit 4 Jun 2025 When soldiers and anti-drug officials dug up 4.4 tons of cocaine at an illegal ...
Request To Download Free Sample of This Strategic Report @ Key Pointers Covered the Growth of the Saudi Arabia Cold-storage Industry: The growth of the Saudi Arabia diabetes cold-storage industry has ...
The current contraceptive landscape places a disproportionate amount of physical and mental burden for pregnancy prevention ...
Health Affairs' Rob Lott interviews Keith Drake of Greylock McKinnon Associates about his recent paper that explores trends ...
DataM Intelligence | competitive Intelligence MPS I market evolution accelerates as gene therapies and BBB-penetrant ERTs emerge, challengi ...
Similarly, resistance to Trop-2-targeted Sacituecan in TNBC has been linked to increased drug efflux activity mediated by MDR transporters ... the potential to significantly enhance the treatment ...